by SWOG Cancer Research Network Credit: Unsplash/CC0 Public Domain Results from the S1609 DART clinical trial, which tested an immunotherapy combination of ipilimumab plus nivolumab in 53 cohorts of patients with rare cancers, are being reported for five cohorts of patients who had rare gynecologic cancers. In three of those five cohorts—the cohorts for clear cell ovarian...
